Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Appl Physiol ; 104(3): 445-53, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18560877

RESUMO

The present study evaluated whether Ca(2+) entry operates during fatigue of skeletal muscle. The involvement of different skeletal muscle membrane calcium channels and of the Na(+)/Ca(2+) exchanger (NCX) has been examined. The decline of force was analysed in vitro in mouse soleus and EDL muscles submitted to 60 and 110 Hz continuous stimulation, respectively. Stimulation with this high-frequency fatigue (HFF) protocol, in Ca(2+)-free conditions, caused in soleus muscle a dramatic increase of fatigue, while in the presence of high Ca(2+) fatigue was reduced. In EDL muscle, HFF was not affected by external Ca(2+) levels either way, suggesting that external Ca(2+) plays a general protective role only in soleus. Calciseptine, a specific antagonist of the cardiac isoform (alpha1C) of the dihydropyridine receptor, gadolinium, a blocker of both stretch-activated and store-operated Ca(2+) channels, as well as inhibitors of P2X receptors did not affect the development of HFF. Conversely, the Ca(2+) ionophore A23187 increased the protective action of extracellular Ca(2+). KB-R7943, a selective inhibitor of the reverse mode of NCX, produced an effect similar to that of Ca(2+)-free solution. These results indicate that a transmembrane Ca(2+) influx, mainly through NCX, may play a protective role during HFF development in soleus muscle.


Assuntos
Sinalização do Cálcio , Cálcio/metabolismo , Líquido Extracelular/metabolismo , Contração Muscular , Fadiga Muscular , Força Muscular , Músculo Esquelético/metabolismo , Animais , Calcimicina/farmacologia , Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio/efeitos dos fármacos , Canais de Cálcio/metabolismo , Sinalização do Cálcio/efeitos dos fármacos , Membrana Celular/metabolismo , Venenos Elapídicos/farmacologia , Estimulação Elétrica , Gadolínio/farmacologia , Técnicas In Vitro , Ionóforos/farmacologia , Camundongos , Contração Muscular/efeitos dos fármacos , Fadiga Muscular/efeitos dos fármacos , Força Muscular/efeitos dos fármacos , Músculo Esquelético/efeitos dos fármacos , Antagonistas do Receptor Purinérgico P2 , Fosfato de Piridoxal/análogos & derivados , Fosfato de Piridoxal/farmacologia , Receptores Purinérgicos P2/metabolismo , Trocador de Sódio e Cálcio/antagonistas & inibidores , Trocador de Sódio e Cálcio/metabolismo , Suramina/farmacologia , Tioureia/análogos & derivados , Tioureia/farmacologia , Fatores de Tempo , Triazinas/farmacologia
2.
Eur J Appl Physiol ; 98(1): 1-21, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16896733

RESUMO

Denervation changes in skeletal muscle (atrophy; alterations of myofibrillar expression, muscle membrane electrical properties, ACh sensitivity and excitation-contraction coupling process; fibrillation), and their possible causes are reviewed. All changes can be counteracted by muscle electrostimulation, while denervation-like effects can be caused by the complete conduction block in muscle nerve. These results do not support the hypothesis that the lack of neurotrophic, non-motor factors plays a role in denervation phenomena. Instead they support the view that the lack of neuromotor discharge is the only cause of the phenomena and that neuromotor activity is an essential factor in regulating muscle properties. However, some experimental results cannot apparently be explained by the lack of neuromotor impulses, and may still suggest that neurotrophic influences exist. A hypothesis is that neurotrophic factors, too feeble to maintain a role in completely differentiated, adult muscles, can concur with neuromotor activity in the differentiation of immature, developing muscles.


Assuntos
Modelos Animais de Doenças , Contração Muscular , Denervação Muscular/métodos , Músculo Esquelético/inervação , Músculo Esquelético/fisiopatologia , Atrofia Muscular/fisiopatologia , Tremor/fisiopatologia , Animais , Humanos , Modelos Biológicos
3.
Am J Physiol Cell Physiol ; 288(6): C1367-73, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15659717

RESUMO

Sphingomyelin derivatives exert various second messenger actions in numerous tissues. Sphingosine (SPH) and sphingosine 1-phosphate (S1P) are two major sphingomyelin derivatives present at high levels in blood. The aim of the present work was to investigate whether S1P and SPH exert relevant actions in mouse skeletal muscle contractility and fatigue. Exogenous S1P and SPH administration caused a significant reduction of tension decline during fatigue of extensor digitorum longus muscle. Final tension after the fatiguing protocol was 40% higher than in untreated muscle. Interestingly, N,N-dimethylsphingosine, an inhibitor of SPH kinase (SK), abolished the effect of supplemented SPH but not that of S1P, suggesting that SPH acts through its conversion to S1P. Moreover, SPH was not effective in Ca(2+)-free solutions, in agreement with the hypothesis that SPH action is dependent on its conversion to S1P by the Ca(2+)-requiring enzyme SK. In contrast to SPH, S1P produced its positive effects on fatigue in Ca(2+)-free conditions, indicating that S1P action does not require Ca(2+) entry and most likely is receptor mediated. The effects of S1P could be ascribed in part to its ability to prevent the reduction (-20 mV) of action potential amplitude caused by fatigue. In conclusion, these results indicate that extracellular S1P has protective effects during the development of muscle fatigue and that the extracellular conversion of SPH to S1P may represent a rheostat mechanism to protect skeletal muscle from possible cytotoxic actions of SPH.


Assuntos
Lisofosfolipídeos/fisiologia , Fadiga Muscular/fisiologia , Músculo Esquelético/fisiologia , Esfingosina/análogos & derivados , Esfingosina/fisiologia , Animais , Cálcio/fisiologia , Relação Dose-Resposta a Droga , Indóis/farmacologia , Lisofosfolipídeos/farmacologia , Maleimidas/farmacologia , Camundongos , Camundongos Endogâmicos , Contração Muscular/efeitos dos fármacos , Contração Muscular/fisiologia , Fadiga Muscular/efeitos dos fármacos , Fosfotransferases (Aceptor do Grupo Álcool)/antagonistas & inibidores , Esfingosina/farmacologia
4.
J Appl Physiol (1985) ; 92(5): 2045-52, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-11960956

RESUMO

Skeletal muscle type 2B fibers normally receive a moderate level of motoneuron discharge. As a consequence, we hypothesize that type 2B fiber properties should be less sensitive to the absence of the nerve. Therefore, we have investigated the response of sarcoplasmic reticulum and myofibrillar proteins of type 2B fibers isolated from rat extensor digitorum longus muscle after denervation (2 and 7 days). Single fibers were identified by SDS-PAGE of myosin heavy chain isoforms. Electrophysiological and isometric contractile properties of the whole muscle were also analyzed. The pCa-tension relationship of type 2B single fibers was shifted to the left at 2 days and to right at 7 days after denervation, with significant differences in the Hill coefficients and pCa threshold values in 2- vs. 7-day-denervated fibers. The sarcoplasmic reticulum Ca2+ uptake capacity and rate significantly decreased after 2 days of denervation, whereas both increased at 7 days. Caffeine sensitivity of sarcoplasmic reticulum Ca2+ release was transitory and markedly increased in 2-day-denervated fibers. Our results indicate that type 2B fiber functional properties are highly sensitive to the interruption of nerve supply. Moreover, most of 2-day-denervated changes were reverted at 7 days.


Assuntos
Fibras Musculares Esqueléticas/fisiologia , Músculo Esquelético/inervação , Músculo Esquelético/fisiologia , Animais , Transporte Biológico/fisiologia , Cafeína/farmacologia , Cálcio/metabolismo , Cálcio/farmacocinética , Cálcio/farmacologia , Denervação , Eletroforese em Gel Bidimensional , Eletroforese em Gel de Poliacrilamida , Técnicas In Vitro , Contração Isométrica/efeitos dos fármacos , Contração Isométrica/fisiologia , Contração Muscular/efeitos dos fármacos , Contração Muscular/fisiologia , Fibras Musculares Esqueléticas/química , Fibras Musculares Esqueléticas/efeitos dos fármacos , Cadeias Pesadas de Miosina/análise , Cadeias Leves de Miosina/análise , Ratos , Ratos Wistar , Retículo Sarcoplasmático/química , Retículo Sarcoplasmático/efeitos dos fármacos , Retículo Sarcoplasmático/metabolismo , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...